ABIGAIL BUNCH: Open Payments
NPI 1285169219 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,810 in 114 payments from 26 companies in 2025. Trend: 2023 $1,290 · 2024 $2,943 · 2025 $2,810
Food & beverage: $2,750Education: $60
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $738 |
| AstraZeneca Pharmaceuticals LP | 8 | $322 |
| ABBVIE INC. | 16 | $266 |
| Axsome Therapeutics, Inc. | 5 | $151 |
| Corcept Therapeutics | 4 | $145 |
| GlaxoSmithKline, LLC. | 10 | $141 |
| MERZ NORTH AMERICA, INC. | 1 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $129 |
| Astellas Pharma US Inc | 3 | $100 |
| Xeris Pharmaceuticals, Inc. | 5 | $92 |
Products named: Wegovy, Ozempic, AIRSUPRA, Rybelsus, Korlym, Auvelity, Xeomin, CAPLYTA.
Industry payments across TN — which companies pay providers there.
